Orthopaedic Surgeon implants first MIDLINE device at Valley Hospital

NewsGuard 100/100 Score

Just days after Centinel Spine's new STALIF MIDLINE™ Integrated Interbody Fusion™ system was unveiled at the annual meeting of the North American Spine Society (NASS), the first MIDLINE device has been successfully implanted by noted Orthopaedic Surgeon, John S. Thalgott, MD at Valley Hospital in Las Vegas, NV.

“During the development of the MIDLINE system, we listened carefully to those surgeons familiar with our STALIF TT™ system to determine what features were essential to the next generation of Integrated Interbody Devices. As a result, we were able to create the genuinely superior system reflected in Dr. Thalgott's verdict.”

On completing the procedure, Dr. Thalgott praised both the MIDLINE implant and the integrated MIDLINE system itself. "The new ABO™ anti back-out screws used in the MIDLINE system provided excellent screw purchase with improved lag effect. The enhanced trials and instruments allowed for a smoother operation all around, rendering the system markedly superior to its predecessors - a great job by Centinel's development team both for me and my colleagues," Dr. Thalgott said.

Centinel Spine's Chairman and CEO, John J. Viscogliosi, said: "During the development of the MIDLINE system, we listened carefully to those surgeons familiar with our STALIF TT™ system to determine what features were essential to the next generation of Integrated Interbody Devices. As a result, we were able to create the genuinely superior system reflected in Dr. Thalgott's verdict."

After attending the first surgery, Centinel's President Michael D. Will added: "Although this was the first MIDLINE case, we believe Dr. Thalgott's favorable comments will be echoed by those surgeons choosing to use the system - representing a worthy successor to our STALIF TT™. That system has been well accepted and widely used for the past 10 years."

The MIDLINE alpha launch is expected to run through January, 2011, at which time a much wider beta launch will be initiated.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lurie Children's Hospital administers first gene therapy for Duchenne muscular dystrophy in Illinois